AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice

Human Gene Therapy

Volumn 12, Issue 5, 2001, Pages 515-526

  Li, H ^a,b   Lindenmeyer, F ^c   Grenet, C ^c   Opolon, P ^b   Menashi, S ^c   Soria, C ^a,c   Yeh, P ^b   Perricaudet, M ^b   Lu, H ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; HUMAN; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0035937312     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401300042429     Document Type: Article

References (57)

1. Adenovirus-mediated gene delivery of tissue inhibitor of metallopro-teinase-3 inhibits invasion and induces apoptosis in melanoma cells
2. A rapidin vitro assay for quantifying the invasion potential of tumor cells
3. Tumor cell invasion inhibited by TIMP-2
4. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
5. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro - TIMP-3 promotes apoptosis
6. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros
7. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases
8. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
9. Clinical studies with matrix metalloproteinase inhibitors
10. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
11. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
12. Anti-angiogenic agents: Clinical trial design and therapies in development
13. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
14. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
15. Angiogenesis in cancer, vascular, rheumatoid and other disease
16. Angiogenesis zip code
17. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2
18. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
19. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
20. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
21. Tissue inhibitor of metalloproteinase-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition
22. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turn-over
23. Overexpression of tissue inhibitor of metal-loproteinase-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
24. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
25. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metallopro-teinase-2 expression in bladder cancer
26. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metallo-proteinase immobilized on agarose beads
27. Tumor targeting with a selective gelatinase inhibitor
28. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix met-alloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
29. Stable transduction of actively dividing cells via a novel adenovirus/episomal vector
30. Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
31. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice
32. Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice
33. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
34. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice
35. Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
36. Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
37. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
38. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
39. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - A predictor of tumour stage
40. Type IV collagenases in tumor invasion and metastasis
41. Mattrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
42. Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector
43. Induction of angio-genesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
44. Targeting angiogenesis: Genetic intervention with strikes at the weak link of tumorigenesis
45. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
46. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
47. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastasis in nude mice
48. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
49. The purification of tissue inhibitor of matrix metalloproteinases-2 from its 72-kDa complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1
50. Matrix-degrading proteases and angiogenesis during development and tumor formation
51. Regulation of matrix metalloproteinase expression in tumor invasion
52. The soluble catalytic domain of membrane type-1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation
53. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A
54. The matrix metalloproteinases family
55. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1)
56. Matrix metalloproteinase inhibitors: Applications in oncology
57. Genomic integration and gene expression by a modified adenoviral vector